Vbi Vaccines Inc CS (VBIV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VBIV | AMGN | VRTX | BMY | GILD |
| Company | Vbi Vaccines Inc CS | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 0.0860 | 275.81 | 454.72 | 58.57 | 92.59 |
| High | 0.0866 | 279.41 | 464.87 | 58.79 | 92.60 |
| Low | 0.0572 | 273.86 | 450.00 | 57.59 | 89.86 |
| Last | 0.0653 | 278.26 | 463.98 | 58.37 | 91.59 |
| Change | -0.0676 | -0.06 | +7.01 | -0.32 | -0.90 |
| % Change | -50.87% | -0.02% | +1.53% | -0.55% | -0.97% |
| Volume | 29,900,200 | 4,174,100 | 1,220,600 | 9,533,600 | 9,124,300 |
| 20-Day Average Volume | 25,749,836 | 4,558,985 | 1,393,970 | 11,525,064 | 7,634,140 |
| Previous Close | 0.1329 | 278.32 | 456.97 | 58.69 | 92.49 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.4605 | 293.66 | 473.23 | 57.96 | 92.02 |
| 20-Day Raw Stochastic | 1.33% | 29.04% | 25.35% | 61.88% | 42.98% |
| 20-Day Relative Strength | 23.48% | 33.90% | 47.01% | 58.04% | 55.36% |
| Weighted Alpha | -64.26 | -4.57 | +23.17 | +24.81 | +24.78 |
| Today's Opinion | 100% Sell | 72% Sell | 8% Sell | 100% Buy | 88% Buy |
| Previous Opinion | 100% Sell | 72% Sell | 8% Sell | 100% Buy | 100% Buy |
| Last Month's Opinion | 100% Buy | 8% Buy | 24% Buy | 88% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -49.50% since 07/31/24 | -0.62% since 11/26/24 | -0.66% since 11/26/24 | -0.63% since 11/26/24 | +0.26% since 11/26/24 |
| Low | 0.0553 on 08/05/24 | 273.86 on 12/04/24 | 450.00 on 12/04/24 | 57.59 on 12/04/24 | 89.86 on 12/04/24 |
| High | 0.2260 on 08/06/24 | 283.64 on 11/29/24 | 470.93 on 11/29/24 | 60.09 on 12/03/24 | 94.39 on 12/03/24 |
| 1-Month | |||||
| %Chg | -91.10% since 07/05/24 | -12.20% since 11/04/24 | -1.87% since 11/04/24 | +5.27% since 11/04/24 | +1.95% since 11/04/24 |
| Low | 0.0553 on 08/05/24 | 257.80 on 11/26/24 | 445.00 on 11/21/24 | 53.97 on 11/08/24 | 86.08 on 11/19/24 |
| High | 0.8098 on 07/12/24 | 328.25 on 11/08/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | -89.15% since 05/07/24 | -15.84% since 09/04/24 | -3.05% since 09/04/24 | +16.83% since 09/04/24 | +15.75% since 09/04/24 |
| Low | 0.0553 on 08/05/24 | 257.80 on 11/26/24 | 445.00 on 11/21/24 | 47.55 on 09/09/24 | 77.74 on 09/05/24 |
| High | 0.8098 on 07/12/24 | 339.17 on 09/23/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | -89.78% since 02/07/24 | -9.47% since 06/04/24 | -2.31% since 06/04/24 | +39.81% since 06/04/24 | +42.75% since 06/04/24 |
| Low | 0.0553 on 08/05/24 | 257.80 on 11/26/24 | 445.00 on 11/21/24 | 39.35 on 07/05/24 | 62.69 on 06/18/24 |
| High | 1.3500 on 04/09/24 | 346.85 on 07/25/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,873 | 149,573,936 | 119,488,304 | 118,384,688 | 114,145,504 |
| Shares Outstanding, K | 28,682 | 537,533 | 257,529 | 2,028,177 | 1,246,266 |
| Annual Sales | 8,680,000 | 28,190,000,000 | 9,869,200,000 | 45,006,000,000 | 27,116,000,000 |
| Annual Net Income | -92,840,000 | 6,717,000,000 | 3,619,600,000 | 8,025,000,000 | 5,665,000,000 |
| Last Quarter Sales | 1,210,000 | 8,503,000,000 | 2,771,900,000 | 11,892,000,000 | 7,545,000,000 |
| Last Quarter Net Income | -17,900,000 | 2,830,000,000 | 1,045,400,000 | 1,211,000,000 | 1,253,000,000 |
| 60-Month Beta | 2.18 | 0.55 | 0.36 | 0.45 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.55 on 05/15/24 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 1.80 on 10/31/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 08/12/24 | 10/30/24 | 11/04/24 | 10/31/24 | 11/06/24 |
| Most Recent Dividend | 0.150 on 12/12/12 | 2.250 on 11/18/24 | N/A | 0.600 on 10/04/24 | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | N/A | 10/04/24 | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.48 | 0.00 | 50.16 | 20.88 |